MERIDIAN INVESTMENT COUNSEL INC. - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 69 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
MERIDIAN INVESTMENT COUNSEL INC. ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2017$52,000
+40.5%
20,0000.0%0.01%
+27.3%
Q3 2017$37,000
+94.7%
20,000
+100.0%
0.01%0.0%
Q2 2017$19,000
-5.0%
10,0000.0%0.01%
-8.3%
Q1 2017$20,00010,0000.01%
Other shareholders
INOTEK PHARMACEUTICALS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,627,790$5,256,0007.39%
FT Options LLC 477,763$956,0001.26%
Sio Capital Management, LLC 726,900$1,454,0000.81%
SENZAR ASSET MANAGEMENT, LLC 852,022$1,704,0000.43%
DAFNA Capital Management LLC 237,135$474,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 401,764$804,0000.16%
DLD Asset Management, LP 439,500$870,0000.14%
Minerva Advisors LLC 64,759$126,0000.07%
SHEPHERD KAPLAN KROCHUK, LLC 36,000$72,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 96,435$193,0000.04%
View complete list of INOTEK PHARMACEUTICALS CORP shareholders